Search
SOLACI Congress
SOLACI CongressesSOLACI-CACI 21

SOLACI-CACI 21

solaci
solaci
231
0

Here you will find the most relevant articles about the SOLACI-CACI 2021 Congress.

If you cannot view the articles, click here.

Previous article
SOLACI-CACI 2021 | PCI image guidance and robotic automation for precise treatment – Siemens Healthineers Symposium
Next article
SOLACI-CACI 2021 | Overcoming Challenges of the BALLOON EXPANDABLE TAVI Cases – EDWARDS Symposium
solaci
solaci

More articles by this author

SOLACI-SBHCI 23

solaci - 0
Here you will find the most relevant articles about the SOLACI-SBHCI 2023 Congress. If you cannot view the articles, click here.

PCI-Advances in DIABETIC PATIENTS – MIL & WIN SESSION – SOLACI-SOCIME 2022

solaci - 0
✔️ PCI-Advances in DIABETIC PATIENTES - MIL & WIN SESSION ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Contents: 00:10 - Welcoming words - Dra. Emma Miranda (MEX)...

SOLACI-SOCIME 22

solaci - 0
Here you will find the most relevant articles about the SOLACI-SOCIME 2022 Congress. If you cannot view the articles, click here.

SOLACI-SBHCI 2019

solaci - 0
Here you will find the most relevant articles about the SOLACI-SBHCI 2019 Congress, held on August 1st, 2nd & 3rd at Frei Caneca Convention...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Congresses

SOLACI-SBHCI 23

Here you will find the most relevant articles about the SOLACI-SBHCI 2023 Congress. If you cannot view the articles, click here.
solaci -
SOLACI Sessionsspot_img

Recent Articles

TAVR in Women

Dr. Carlos Fava - 0
Severe aortic stenosis (AS) in women shows distinct features, compared to men, with lower prevalence of heart disease, among other differences. However, women have...

Early and Late Readmission after Left Atrial Appendage Closure

Dr. Juan Manuel Pérez - 0
Percutaneous left atrial appendage closure (LAAC) represents an effective alternative for patients with atrial fibrillation and anticoagulation contraindication. This study looked at incidence, predictors...

OCT Assessment of Bioresorbable Scaffold Performance across Different Types of Plaque

Dr. Omar Tupayachi - 0
The development of bioresorbable magnesium scaffolds (RMS) has generated significant expectation in the field of percutaneous coronary intervention, especially because it could potentially restore...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

TAVR in Women

Dr. Carlos Fava - 0
Severe aortic stenosis (AS) in women shows distinct features, compared to men, with lower prevalence of heart disease, among other differences. However, women have...

Early and Late Readmission after Left Atrial Appendage Closure

Dr. Juan Manuel Pérez - 0
Percutaneous left atrial appendage closure (LAAC) represents an effective alternative for patients with atrial fibrillation and anticoagulation contraindication. This study looked at incidence, predictors...

OCT Assessment of Bioresorbable Scaffold Performance across Different Types of Plaque

Dr. Omar Tupayachi - 0
The development of bioresorbable magnesium scaffolds (RMS) has generated significant expectation in the field of percutaneous coronary intervention, especially because it could potentially restore...

Institutional News

Data Update Campaign for SOLACI Members. Let’s Stay Connected

solaci - 0
Data Update for SOLACI Members. We aim to keep our members informed about all developments and matters related to the association. In this regard, we...

Highlights of the SOLACI@EuroPCR 2025 Session

solaci - 0
Relive the best moments of the joint session organized by SOLACI during the EuroPCR 2025 Congress on “Clinical and technical factors for decision-making in...

SOLACI Symposium at the EuroPCR 2025 Congress

solaci - 0
The Latin American Society of Interventional Cardiology (SOLACI) makes a strong appearance once again at one of the most important congresses in the field...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy